09 February 2012

PDF link: Result Update: Jaiprakash Power, India Cements, ICRA, Nava Bharat Ventures Ltd, Cadila Healthcare, HEG, Hindustan Unilever, Ballarpur Industries, Mahindra & Mahindra Ltd:: EMkay

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Result Update

Jaiprakash Power
Reco: HOLD
CMP: Rs 45
Target Price: Rs 45
Fairly valued now; Downgrade to Hold
·      3Q12 PAT at Rs595mn – ahead of expectations driven by higher income from sale of VERs (Rs292mn) and higher merchant realizations (Rs4.7/unit) from Karcham 
·      Issues/overhang on JPVL - (1) huge funding gap for equity inv and to repay corporate debt, (2) uncertainty on Karcham offtake, (3) fuel availability and (4) captive mine under no-go
·      Issues addressed - (1) few projects on hold - lower funding  & fuel needs, (2) high court’s order on Karcham & healthy internal accruals - easing of cash flows, (3) forest clearance of Nigrie mine in few mths & (4) use of captive coal for Bina
·      Upgraded the stock to Buy post last qtr, it has outperformed nifty by 23% since. Do not see upside from these levels unless clarity emerges on (1) funding NCD repayment, (2) forest clearance for Dongri-tal II & (3) use of captive coal in Bina

BUY :Target: INR 471 Elder Pharmaceuticals Ltd.:: Unicon

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Buy
CMP: INR 347
Target: INR 471
Elder Pharmaceuticals Ltd. is an integrated pharmaceutical company that is mainly involved in manufacturing & sales of
branded formulations and Active pharmaceutical Ingredient (API). Elder has its presence in niche therapeutic segments
like women’s healthcare, wound & pain management, Neutraceuticals and Lifestyle disease care portfolio with strong
brands like Shelcal, Eldervit, Chymoral etc that have dominant market shares in their respective segments. The company
has strong alliances with almost 24 international innovator companies for in-licensing their products in India.
Investment Rationale
Strong domestic foothold
Elder derives 76% of its revenue from Domestic business and has been a strong player in branded formulation space.
The company has some strong brands like Shelcal, Eldervit, and Chymoral that has established Numero –Uno
positions amongst their peers. Most of its brand has a dominant market share in its respective segments. Domestic
business has been the primary focus of the company with the extensive brand portfolio across therapies. Despite
strong competition in the domestic market, Elder has been able to maintain its growth rate due to its strong brand
image and strong rapport with the medical fraternity.
In-licensing deals & Strong product pipeline
Elder generates around 6% of its revenue from in-licensing deals. Elder has successful in-licensing agreements with
around 24 international innovator companies, for marketing their products in India. Considering Elder’s past record
of the in-licensing deals and its ability to convert the products into big brands, the alliances with innovators seem to
be a positive future growth strategy for the company. The company has a strong product pipeline of around 35
products, which are expected to be launched over a period of 3-4 yrs.
Wide network coverage and expansion of geographic presence
Elder is concentrating on expanding marketing & distribution reach with a particular focus on rural & semi-urban
markets, thus strengthening its domestic business. The company has taken initiatives like creating new divisions viz;
Elvista & Adventus, increasing MR strength and widening the therapeutic coverage. Currently, Elder covers
approximately, 410000 doctors and 80,000 pharmacies every month.
International acquisition to aid the company’s growth
Elder recently acquired 100% stake in UK based NeutraHealth Plc, with an aim to gain access to the multiple brands
in the UK and establish a footprint in the regulated EU markets. The acquisition of NeutraHealth with an investment
of INR 1340 mn has been a synergetic operation. With an intention of entering the German market, Elder acquired
Biomeda Ltd. (having a stake of 92.2% in the company) with an investment of INR 400 mn. Elder is expected to
make a CAPEX of around INR 220 mn in Biomeda, for up-gradation of its facilities and make it EU compliant.
Outlook & Valuation
The stock currently trades at 8.3x & 6.4x its FY12e and FY13e earnings. Given the strong presence in domestic space and
product pipeline with market leading brand portfolio, the growth prospects of the company look very strong. We
recommend Elder Pharmaceuticals Ltd. with BUY rating and a target price of 471, valuing the stock at 8.5x its FY13e
earnings with medium to long-term perspective.

Buy Rural Electrification Corp: TP: INR235:: Motilal oswal,

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Rural Electrification Corp's (RECL) 3QFY12 PAT grew 16% YoY and 24% QoQ to INR7.7b (15% higher than estimates),
helped by a forex gain of INR866m. Loan growth remained healthy at 25% YoY but reported margins contracted
13bp QoQ. Asset quality deteriorated with one large power project being classified as NPA. Key highlights:
 NII grew 18.5% YoY and 5.8% QoQ to INR10b; in line with our estimates. However, reported NIM contracted
13bp sequentially to 4.34% mainly on account of reversal in interest income to the tune of ~INR220m (due to
a large power project being classified as non-performing), which impacted yield on loans.
 Loans grew 25% YoY and 5% QoQ to INR950b. The overall loan mix remained fairly stable. Exposure to private
sector continued to inch up steadily, rising to 12% v/s 11.2% in 2QFY12 and 9.1% in 3QFY11.
 RECL booked forex gain of INR866m (v/s estimates of a forex loss of INR1b) due to change in accounting
treatment for foreign currency translation difference. Had the company followed the old accounting method,
the 9MFY12. PAT would have been lower by INR1.97b.
 Asset quality deteriorated with GNPAs increasing to INR4.9b from INR2.7b in 2QFY12, on account of one large
gas based power project being classified as NPA. RECL's exposure to this project stood at INR2.2b.
Valuation and view: We fine tune our earnings estimates and expect earnings CAGR of 16%, with average RoAs of
~3% over FY12/13. While we expect RoA to decline ~25bp over FY11-FY13 owing to a compression in NIMs, RoE
would continue to remain strong at 21-22% as REC leverages its capital. Stock trades at 1.1x FY13E BV. Buy.

Buy Bharti Airtel ; Target : Rs 450 :: ICICI Securities, (pdf link)

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


PDF LINK for report- click HERE



M o U   d o w n ;   A R P M   i n c r e a s e s …
Bharti Airtel declared its Q3FY12 numbers, which were slightly better than
our topline estimates but below our  estimates on the PAT front. The
company reported a topline of | 18476.7 crore against our expectation of
| 18294.0 crore, registering QoQ growth of 7.0%. The EBITDA margin,
however, declined 155 bps QoQ due to higher marketing costs and higher
access charges. EBITDA for the quarter stood at | 5927.3 crore against
our expectation of | 6111.0 crore.  The PAT for the company stood at
| 1011.3 crore as against our expectation of | 1374.6 crore, de-growing
1.5% QoQ marred by higher depreciation cost and higher tax rate. The
depreciation for the quarter stood at | 3584.5 crore against | 3183.9 crore
in Q2FY12 as it included 3G license fee amortisation of | 164 crore. The
tax rate increased from 32.4% in Q2FY12 to 35.2% in Q3FY12.
Highlights of the quarter
ARPU for India stood at | 187, up from | 183, improving 2.2% QoQ. MoU,
however, saw a decline of 1.0% from | 423 in Q2FY12 to | 419 in Q3FY12.
ARPM surprised positively by improving by 3.2% to 44.6 paisa from 43.2
paisa while the traffic increased from 217.4 billion minutes to 219.1 billion
minutes. The Indian subscriber base grew by 1.7% sequentially to 175.7
million. ARPU for the African operations decreased 2.3% to $7.1 while the
subscriber base grew by 5.2% to 50.9 million.
V a l u a t i o n
Though the MoU reduced in the quarter responding to the recent price
hike, ARPM and ARPU improved. The SC ruling of cancelling 122 licenses
is  very  favourable  to  Bharti  Airtel.  We  expect  the  company  to  post
revenue and PAT CAGR of 17.1% and 15.6% over FY11-13E, respectively.
At the CMP of | 350, the stock is trading at 26.8x FY12E and 16.5x FY13E.
Using DCF methodology and assuming revenue CAGR of 10.8% over
FY11–20E and terminal growth of 3.0%  thereon,  we  have  arrived  at  a
target price of | 450/share. We reiterate our BUY rating on Bharti Airtel.

Q3FY12 RESULTS UPDATE Surprise on the upside:: Edelweiss

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��

At little more than the half way mark, results have been broadly ahead of
our expectations. Sectoral analysis reveals that strain remains within PSU
banks (deteriorating asset quality) and cap goods (stagnating power
sector order book and declining margins) while bright spots have been
consumer sector (robust topline growth), private sector banks (better
than expected asset quality) and pharma (a better than expected growth
in US markets). Meanwhile, the overall downgrade cycle has been
relatively benign with a 1% cut in FY13 Sensex EPS so far.
Results broadly above expectations so far
For the BSE‐200 universe companies within our coverage (which have announced
results so far), profit growth at 5.6% YoY has been ahead of expectations. However,
with more than 50% of the BSE‐200 universe already having reported, we may well end
up seeing another quarter of sub‐10% earnings growth (Edelweiss expectations: 2.0%
YoY for the coverage universe). This apart, the headline story has followed the usual
script: heady topline growth (25.6% YoY) punctuated by shrinking EBITDA margins
(17.4% in Q3FY12 vs 21.2% in Q3FY11).
Cap goods, PSU banks laggards, Consumers, Pvt banks outshine
Sector‐wise, few broad trends have emerged even as some of the pain‐points which we
observed for the last few quarters seem to persist. For example, the weakness in power
sector is being reflected in the order book status of BHEL wherein order intake declined
sharply for 9MFY12 by 60% YoY to INR153bn. Trends from PSU banks suggest that some
large ticket accounts would be slipping into NPLs even as few major accounts were
being restructured, leading to higher provisioning costs. Within the IT sector, results
were broadly in line with expectations, but management commentaries about Q4
concern us. Infosys guided for flat revenue growth in March 2012 quarter while TCS
highlighted few project delays.
However, there have been some bright spots as well: 1) better than expected results
within the consumer sector buoyed by a robust topline growth, 2) better asset quality
for private banks, specially within the mid‐cap space (Yes Bank and Federal Bank) and 3)
surprise on the upside from pharma sector on the back of favorable currency
movements and a better than expected growth in US markets.
Meanwhile, within oil & gas results, Reliance Industries disappointed owing to lower
gas production from KG‐D6 (down 3.3 mmscmd sequentially to 41.9 mmscmd) and
lower refining margins. A strong demand for LNG led to a better than expected result
for Petronet LNG

Pdf link: Bharti Airtel, Mahindra & Mahindra, Cadila Healthcare, IL&FS Transportation Networks, Bajaj Corp, Opto Circuits India, Zydus Wellness:: ShareKhan

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��

Click here to read report: Investor's Eye



STOCK UPDATE
Bharti Airtel 
Cluster: Apple Green
Recommendation: Buy
Price target: Rs450
Current market price: Rs354
Price target revised to Rs450
Result highlights
  • Results below expectation: Bharti Airtel (Bharti)'s Q3FY2012 earnings fell short of our as well as the Street's expectations. The adjusted net profit for the quarter stood at Rs1,003 crore (-15.7% quarter on quarter [QoQ]) and the same was 23% lower than our expectation. The biggest negative surprise for the quarter came in the form of a 140bps QoQ contraction in the operating margins. The consolidated operating margin for the quarter came in at 32.2% vs our expectation of 34.4%.

Freight Forward: Shipping Sector Update - February 2012 ::ICICI Sec (pdf link)

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��

PDF LINK for report- click HERE


S h i p p i n g   M o n t h l y   R e p or t   –   F e b r u a r y   2 0 1 2
• The year 2012 began on a disastrous note for the Baltic Dry
Index (BDI), which crashed by 61% MoM to 680 in January,
2012. Capesize, Panamax and Supramax indices declined on
an MoM bias by 56%, 56%, and 44%, respectively. Lack of
Chinese activity in the commodity markets owing to the
Chinese New Year celebrations and high volume of new ship
deliveries led to lower fleet  utilisation and pushed freight
rates downwards
• The Dirty Tanker Index declined 13% MoM to 813 while the
Clean Tanker Index fell sharply by 28% to 651 level in
January 2012. Both indices opened gap down by more than
10% in January 2012 after the year end closing in the last
week of December 2011. Though both indices declined on an
MoM basis due to huge gap down openings, average vessel
rates across categories showed positive momentum post the
subdued opening in January 2012. The rates displayed some
weakening towards the end of the month
• LPG freight rates in January 2012, displayed a mixed trend.
VLGCs recorded smart gains of ~ 5% MoM while other
vessel categories remained flattish in the range of -1% to 2%
• Utilisation levels for drill ships declined from 82% to 78%,
while semi-subs and jack-ups utilisation remained stable at
85% and 81%, respectively, in January 2012
Outlook
Dry bulkers
In the near term, dry bulk freight rates are expected to rebound after the
Chinese industrial sector restarts post the New Year holidays, which
would lead to an increase in seaborne trade and increased demand for
vessels. Over the longer term, freight rates are expected to remain weak
due to high level of Chinese iron ore inventory and significantly high fleet
addition over the next two years.
Tankers
In the near term, tanker freight  rates could see a positive momentum
owing to escalating tension between European nations and Iran. However,
over the longer term, crude oil tanker freight rates are expected to remain
subdued owing to the oversupply of tonnage with 11% of present fleet
expected to be delivered in 2012, which would handicap the market.
LPG carriers
LPG freight rates are expected to  continue the positive momentum,
particularly for VLGCs, while MGCs freight rates are expected to remain
range bound with a positive bias.
Offshore vessels
Utilisation levels for offshore vessels are expected to improve while
charter rates are expected to remain range-bound with a positive bias in
January 2012. High capex spend by major global oil exploration/drilling
companies is likely to lead to higher utilisation levels for offshore vessels.

BSE, Bulk deals, 9/2/2012

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Deal DateScrip CodeCompanyClient NameDeal Type *QuantityPrice **
9/2/20125121618K Miles SoftwareTHOTTATHIL PUTHANPOIRAYIL SAIRAS3532558.80
9/2/2012511706Action FinSEKSARIA INDUSTRIES PVT. LTDB5500045.25
9/2/2012533296Agre DevelopersADIKARAN FINCOM LIMITEDB13020036.48
9/2/2012533296Agre DevelopersANJANA PROJECTS LIMITEDS13000036.47
9/2/2012531560Aroma EnterprisesAARAV FINANCIAL SERVICES PRIVATE LIMITEDB3049009.96
9/2/2012531560Aroma EnterprisesRUPESH BHOGILAL BHATIAS300009.90
9/2/2012531560Aroma EnterprisesPRIYAL INTERNATIONAL PRIVATE LIMITEDS4800010.25
9/2/2012531560Aroma EnterprisesPRIYAL INTERNATIONAL PRIVATE LIMITEDS2000009.90
9/2/2012502219Borosil GlassBOROSIL GLASS WORKS LIMITED BUY BACKB24815850.00
9/2/2012530309Chandra Prabhu-$SANJAY KUMAR PILAB2000018.20
9/2/2012530309Chandra Prabhu-$DINESH KUMAR MODIB2000017.15

9/2/12: FII & DII Turnover (BSE + NSE) (Rs. crore)

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��



FII & DII Turnover (BSE + NSE)
(Rs. crore)
FIIDII
Trade DateBuySalesNetBuySalesNet
9/2/123,985.222,784.561,200.66964.392,001.97-1,037.58

9/2/12: Categories Turnover (BSE) (Rs. crore) Clients NRI Proprietary Trade Data

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��



Categories Turnover (BSE)

(Rs. crore)
ClientsNRIProprietary
Trade DateBuySalesNetBuySalesNetBuySalesNet
9/2/122,182.612,169.3513.261.550.560.99862.43780.1082.33
8/2/122,320.552,358.37-37.820.600.92-0.32886.65828.6857.97
7/2/122,193.812,172.3721.441.351.52-0.18810.16785.4524.71
Feb , 1215,190.5116,727.80-1,537.298.898.790.105,770.035,484.42285.61
Since 1/1/1250,122.9651,922.59-1,799.6225.8228.74-2.9217,766.7717,096.68670.10

NSE, Bulk deals, 09-Feb-2012

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


DateSymbolSecurity NameClient NameBuy / SellQuantity TradedTrade Price /
Wght. Avg.
Price
Remarks
09-Feb-2012AGREAgre Developers LtdADIKARAN FINCOM LTD.BUY1,34,80036.50-
09-Feb-2012AGREAgre Developers LtdANJANA PROJECTS LTDSELL1,35,00036.50-
09-Feb-2012IGLIndraprastha Gas LimitedHDFC STANDARD LIFE INSURANCE COMPANY LIMITEDBUY7,87,707335.32-
09-Feb-2012IVRCLINFRAIVRCL LimitedARCADIA SHARE & STOCK BROKERS PRIVATE LIMITEDBUY16,60,65657.03-
09-Feb-2012IVRCLINFRAIVRCL LimitedARCADIA SHARE & STOCK BROKERS PRIVATE LIMITEDSELL16,54,08557.05-
09-Feb-2012IVRCLINFRAIVRCL LimitedDAMANI MANMOHANBUY15,80,00057.00-
09-Feb-2012IVRCLINFRAIVRCL LimitedDAMANI MANMOHANSELL15,80,00057.47-
09-Feb-2012JINDALSWHLJindal SouthWest Hold LtdCROSSEAS CAPITAL SERVICES PVT. LTD.BUY99,813979.26-
09-Feb-2012JINDALSWHLJindal SouthWest Hold LtdCROSSEAS CAPITAL SERVICES PVT. LTD.SELL99,813978.58-

FII DERIVATIVES STATISTICS FOR 09-Feb-2012

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


FII DERIVATIVES STATISTICS FOR 09-Feb-2012 
 BUYSELLOPEN INTEREST AT THE END OF THE DAY 
 No. of contractsAmt in CroresNo. of contractsAmt in CroresNo. of contractsAmt in Crores 
INDEX FUTURES666801787.95687941845.5057158415466.98-57.54
INDEX OPTIONS54090914334.1053150214084.01150058940595.69250.09
STOCK FUTURES663981919.52754572178.69104086130347.32-259.17
STOCK OPTIONS22850670.3523790701.09567071619.16-30.74
      Total-97.36
 


-- 

Buy PTC India; Target : Rs 62 ::ICICI Securities

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


E r r a t i c   s h o r t - t e r m   m a r ke t   s p o  i l  s   t h  e   s h  o w  …
PTC India reported a disappointing set of Q3FY12 numbers as volume degrowth of 22% YoY was below our expectations of 11% YoY growth.
Hence, the volumes traded for Q3FY12 stood at 4.6 billion units (BUs) (Idirect estimate: 6.5 BUs). Sales stood at | 1330 crore vs. our expectation
of | 2343 crore. Core trading margins in Q3FY12 stood at 4 paisa (I-direct
estimate: 4.5 paisa) whereas the same stood at 4.5 paisa for H1FY12.
Similarly, PAT declined 75% YoY and 72% QoQ as a 47% QoQ rise in
interest costs and 70% QoQ fall in treasury income impacted the same.
ƒ Erratic short term market volumes disturb operational performance
For Q3FY12, volumes in the short-term market have declined by 48%
QoQ given the company has stopped trading with SEBs like Tamil Nadu
and Uttar Pradesh as  | 1100 crore of dues are still pending from the
SEBs. On the other hand, volumes from long-term PPAs and cross border
trades stood at 123.3 million units  (MUs) and 106.4 MUs, respectively.
Core trading margins for Q3FY12 stood at 4 paisa/unit whereas
realisations per unit stood at | 2.9/unit.
ƒ Negative sentiments of SEBs to lead to decline in volumes
Rising risk perception of non payment of dues from SEBs (deteriorating
financial health) will impact the short-term volumes, in our view. The
management expects flattish volumes for FY12. For FY13E, we have
reduced our estimates of trading volumes by 25% to 29 BUs. Coupled
with this, we have reduced our treasury income estimates, which will lead
to a decline in PAT estimates  for FY12 and FY13 by 21% and 22%,
respectively.
V a l u a t i o n
In line with the reduction in our PAT estimates for FY12 and FY13, we
have reduced our target price to | 62/share (| 80 earlier) to incorporate
the fall in trading volumes and treasury income. We believe that until
clarity on SEB dues emerges, the stock will languish till such time.